Literature DB >> 31097893

Melioidosis-Series of Seven Cases from Madurai, Tamil Nadu, India.

Vithiya Ganesan1, Raja Sundaramoorthy1, Sankar Subramanian2.   

Abstract

We describe a case series of seven culture proven melioidosis patients presenting during 2014 to 2016 in Madurai, south Tamilnadu. Skin, soft tissue, bone and joint infections were common. All of them were middle aged men except one case. All the cases were reported during the monsoon season. Predisposing factors include diabetes and alcoholism. Despite many case reports and studies from South India, melioidosis still remains undiagnosed, hence under reported from many centers. Delayed diagnosis leads way to sepsis and other complications. Awareness about the preventive measures, earlier clinical and laboratory identification and appropriate management of severe sepsis are required to reduce the burden of this disease. HOW TO CITE THIS ARTICLE: Ganesan V, Sundaramoorthy R et al., Melioidosis-Series of Seven Cases from Madurai, Tamil Nadu, India. Indian J Crit Care Med 2019;23(3):149-151.

Entities:  

Keywords:  Abscess; Diabetes; Meliodosis

Year:  2019        PMID: 31097893      PMCID: PMC6487615          DOI: 10.5005/jp-journals-10071-23139

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


INTRODUCTION

Melioidosis is an emerging infectious disease of major public health concern in southeast Asia. Many cases have been reported from different regions of India but represent only tip of the iceberg as they are mostly reported from few large medical centers, where identification is possible[1-4]. In this report, we describe a case series of melioidosis patients presented during 2014 to 2016 in Tamil Nadu.

CASE SERIES

All of them were middle aged men except one case. They were presented with skin, soft tissue, bone and joint infections. All the cases were reported during the monsoon season. Predisposing factors include diabetes and alcoholism. In all the cases, pus culture grewBurkholderia pseudomallei. Gram staining of the pus showed Gram-negative bacilli with bipolar staining. The pus culture showed lactose fermenting pink colonies in MacConkey's agar on 1st day which turned dry and wrinkled on day 2 (Figure 1). Blood agar showed dry and wrinkled colonies on day 2. The organism was confirmed to beB. pseudomallei by the above mentioned culture characteristics and standard biochemical methods (positive oxidase and nitrate reduction test, nonfermentingreaction with triple sugar iron agar, hydrolyse arginine, oxidise glucose and lactose). All the isolates were sensitive to cotrimoxazole, doxycycline, ceftazidime, piperacillin tazobactam and meropenem. Bacteremia was confirmed in three cases. Acute renal injury was the most common organ dysfunction found in all the patients. Three patients died of sepsis due to delayed diagnosis and inappropriate management (Table 1).
Fig. 1

B. pseudomallei in MacConkey agar

Table 1

Demographic details, risk factors and outcome of the cases

Cases
1234567
Age52473165314667
SexMMFMMMM
Presenting monthDecemberJanuaryJanuaryDecemberNovemberSeptemberOctober
Risk factorDMDMDMDM, alcoholismDMDM, alcoholismDM, alcoholism
Clinical presentationElbow and knee arthritisFoot cellulitisGluteal abscessMultiple metastatic pyogenic abscessOsteomyelitis with intramuscular abscessPyelonephritis, sepsis, knee arthritisCellulitis leg, sepsis
Blood sugarRecurrent hypoglycemia116395214216458372
Hb812.28.211.61010.59.6
TC10,90019,30012,20017,20023,50013,3002200
ESR83225536213339
Antibiotic sensitivityS to CAZ, IMI, CIP, COT, CFSS to CAZ, COT, DOXS to CAZ, IMI, MER, CIP, PITS to CAZ, MER, IMI, COT, PIT, CIPS to CAZ, PIT, IMI, CIP, COTS to CAZ, CIP, IMI, PITS to CAZ, CIP, IMI, PIT
BacteremiaAbsentAbsentAbsentPresentPresentPresentAbsent
Organ dysfunctionAcute renal injuy, hypoxic ischemic encephalopathyRaised renal paramtersNilRenal and hepatic dysfunctionRenal dysfunctionRenal and hepatic dysfunctionAcute renal injury
TreatmentMER, CAZI & D, CAZI & D, PITIMI, I & D of inguinal abscess, splenectomy and drainage of liver abscessI & D of intramuscular abscessImipenem for 2 weeksImipenem started
Maintenance phase-DOXAmoxyclav--COT
OutcomeDiedRecoveredRecoveredDiedDiedRecoveredLost to followup

CAZ: Ceftazidime, IMI: Imipenem, CIP: Ciprofloxacin, COT: Cotrimoxazole, CFS: Cefoperazone Sulbactum, DOX: Doxycycline, MER: Meropenem, PIT: Piperacillin Tazobactum

DISCUSSON

B. pseudomallei is an environmental Gram-negative bacterium and etiological agent of melioidosis. It is generally less virulent in healthy hosts but patients with diabetes mellitus, in particular type 2 diabetes, show a high incidence of melioidosis. In Type 1 diabetes mellitus, use of m-cresol (a preservative) with insulin has an inhibitory effect on the organism[5]. This can be attributed for the high incidence in Type 2 diabetes. B. pseudomallei is known to survive and multiply within cell lines of macrophage/monocyte and neutrophils. Also, the comorbid risk factors for melioidosis contribute by impairing neutrophil function. In diabetes mellitus, neutrophil is structurally and functionally affected thus unable to perform optimally during inflammation. The function still deteriorates during acute and chronic hyperglycemic states. Such type of defects are also observed in association with high alcohol consumption, chronic renal failure and thalassemia. As in tuberculosis, there is a possibility of dormant state of melioidosis in macrophages as there are reported relapses after apparently successful treatment. So, cell mediated immunity plays a prime role in the control of this organism. B. pseudomallei in MacConkey agar Demographic details, risk factors and outcome of the cases CAZ: Ceftazidime, IMI: Imipenem, CIP: Ciprofloxacin, COT: Cotrimoxazole, CFS: Cefoperazone Sulbactum, DOX: Doxycycline, MER: Meropenem, PIT: Piperacillin Tazobactum B. pseudomallei is transmitted by inhalation, ingestion and inoculation. There is a strong association with monsoonal rains, and occupational and recreational exposure to surface water. In our centre, all the cases were reported during the monsoon. Cellulitis, arthritis, osteomyelitis, pyelonephritis and abscesses were the clinical presentations. Skin and soft tissue infections were rapidly progressive, mimicking necrotizing fasciitis from other organisms like Streptococcus and filamentous fungi. High proportions of patients can present with internal abscess, like in one of our cases, multiple pyogenic abscess with liver and spleen involvement. Markers of organ dysfunction including leucopenia, elevated liver enzymes, renal parameters and metabolic derangements (hypoglycemia and acidosis) during admission appear to predict mortality. In the present case series, renal dysfunction and metabolic derangements were markers of impending mortality. As the microbiological clearance is slow, repeated positive cultures and persistent radiological abnormalities does not necessarily mean a poor prognosis. B. pseudomallei exhibits resistance to penicillins, amino- glycosides and relatively insensitive to macrolides and flouroquinolones. So, treatment options are limited. Ceftriaxone and cefotaxime use is associated with a higher failure rate among patients with melioidosis[6]. Ceftazidime and carbapenems remain the drugs of choice during the intensive phase therapy. Use of meropenem especially in severe sepsis is advocated. This is supported by a retrospective study of meropenem use in Australia, in which statistically significant decrease in mortality was seen in meropenem-treated patients with severe sepsis compared with use of ceftazidime only, despite confounding factors like use of Granulocyte colony stimulating factor[7]. Cotrimoxazole with or without doxycycline is used for the prolonged eradication phase. Doxocycline should not be used as monotherapy as drugresistance is expected[8]. Adherence to therapy (24-week course of therapy) is the major factor that prevents relapse.

CONCLUSION

To diagnose melioidosis promptly, a high index of suspicion in certain clinical settings cannot be overemphasized. Delayed diagnosis leads way to sepsis and other complications. Awareness about the preventive measures, earlier clinical and laboratory identification, and appropriate management of severe sepsis are required to reduce the burden of this disease.
  8 in total

1.  Empirical cephalosporin treatment of melioidosis.

Authors:  W Chaowagul; A J Simpson; Y Suputtamongkol; N J White
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

2.  Interaction of insulin with Burkholderia pseudomallei may be caused by a preservative.

Authors:  A J Simpson; V Wuthiekanun
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

3.  Melioidosis: Series of Eight Cases.

Authors:  Ujjwayini Ray; Soma Dutta; Suresh Ramasubban; Dhiman Sen; Indrajeet Kumar Tiwary
Journal:  J Assoc Physicians India       Date:  2016-05

4.  Melioidosis :an emerging infection in India.

Authors:  R Gopalakrishnan; D Sureshkumar; M A Thirunarayan; V Ramasubramanian
Journal:  J Assoc Physicians India       Date:  2013-09

5.  Outcomes of patients with melioidosis treated with meropenem.

Authors:  Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Dianne P Stephens; Susan P Jacups; Bart J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.

Authors:  A W Jenney; G Lum; D A Fisher; B J Currie
Journal:  Int J Antimicrob Agents       Date:  2001-02       Impact factor: 5.283

7.  Septicaemic melioidosis in a tertiary care hospital in south India.

Authors:  Mary V Jesudason; Anand Anbarasu; T Jacob John
Journal:  Indian J Med Res       Date:  2003-03       Impact factor: 2.375

8.  Melioidosis--a case series from south India.

Authors:  Kavitha Saravu; Satya Vishwanath; Raghu Suresh Kumar; Ananthakrishna Shastry Barkur; George K Varghese; Chiranjay Mukhyopadhyay; Indira Bairy
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-12       Impact factor: 2.184

  8 in total
  1 in total

1.  Melioidosis in a Tertiary Care Center from South India: A 5-year Experience.

Authors:  Vithiya Ganesan; Mariappan Murugan; Raja Sundaramurthy; Geni Vg Soundaram
Journal:  Indian J Crit Care Med       Date:  2021-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.